Corcept Therapeutics (CORT)
Develops cortisol-modulating medicines for endocrine disease and cancer.
$115.61
vs last close−1.89 (−1.61%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
in 42 days
EPS estimate
$0.81
Revenue estimate
$323.9M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Jul '25Nov '25Feb '26Apr '26Jul '26Nov '26
Reported$0.26$0.17$0.29$0.16$0.20−$0.30$0.36Pending
Estimate$0.37$0.17$0.23$0.18$0.33−$0.11$0.02$0.81
Surprise−29.7%0.0%+26.1%−11.1%−39.4%−172.3%+1,383.3%—
RevenueReportedEstimate
Feb '25May '25Jul '25Nov '25Feb '26Apr '26Jul '26Nov '26
Reported$181.9M$157.2M$194.4M$207.6M$202.1M$164.9M$256.1MPending
Estimate$200.1M$216.7M$244.6M$255.3M$254.9M$185.3M$221.1M$323.9M
Surprise−9.1%−27.4%−20.5%−18.7%−20.7%−11.0%+15.8%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $1.25 | — | — |
| Sep 2027 | $1.57 | — | — |
| Jun 2027 | $1.23 | — | — |
| Mar 2027 | $0.48 | — | — |
| Dec 2026 | $1.16 | — | — |
| Nov 2026 | $0.81 | — | — |
| Jul 2026 | $0.02 | $0.36 | +1,383.3% |
| Apr 2026 | −$0.11 | −$0.30 | −172.3% |
| Feb 2026 | $0.33 | $0.20 | −39.4% |
| Nov 2025 | $0.18 | $0.16 | −11.1% |
| Jul 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $1.25 | — | — | $453.8M | — | — | — |
| Sep 2027 | $1.57 | — | — | $485.7M | — | — | — |
| Jun 2027 | $1.23 | — | — | $427.5M | — | — | — |
| Mar 2027 | $0.48 | — | — | $318.6M | — | — | — |
| Dec 2026 | $1.16 | — | — | $373.8M | — | — | — |
| Nov 4, 2026 | $0.81 | — | — | $323.9M | — | — | — |
| Jul 29, 2026 | $0.02 | $0.36 | +1,383.3% | $221.1M | $256.1M | +15.8% | +27.3% |
| Apr 30, 2026 | −$0.11 | −$0.30 | −172.3% | $185.3M | $164.9M | −11.0% | +10.5% |
| Feb 24, 2026 | $0.33 | $0.20 | −39.4% | $254.9M | $202.1M | −20.7% | −0.7% |
| Nov 4, 2025 | $0.18 | $0.16 | −11.1% | $255.3M | $207.6M | −18.7% | +7.8% |
| Jul 31, 2025 | |||||||
| May 5, 2025 | |||||||
| Feb 26, 2025 | |||||||
| Oct 30, 2024 | |||||||
| Jul 29, 2024 | |||||||
| May 1, 2024 | |||||||
| Feb 15, 2024 | |||||||
| Nov 1, 2023 | |||||||
| Aug 2, 2023 | |||||||
| May 3, 2023 | |||||||
| Feb 28, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 3, 2022 | |||||||
| May 5, 2022 | |||||||
| Feb 15, 2022 | |||||||
| Nov 3, 2021 | |||||||
| Jul 29, 2021 | |||||||
| May 6, 2021 | |||||||
| Feb 23, 2021 | |||||||
| Nov 3, 2020 | |||||||
| Aug 4, 2020 | |||||||
| May 4, 2020 | |||||||
| Feb 20, 2020 | |||||||
| Nov 7, 2019 | |||||||
| Aug 1, 2019 | |||||||
| May 9, 2019 | |||||||
| Feb 25, 2019 | |||||||
| Nov 1, 2018 | |||||||
| Aug 9, 2018 | |||||||
| May 8, 2018 | |||||||
| Feb 22, 2018 | |||||||
| Nov 2, 2017 | |||||||
| Aug 1, 2017 | |||||||
| May 1, 2017 | |||||||
| Mar 6, 2017 | |||||||
| Nov 1, 2016 | |||||||
| Aug 2, 2016 | |||||||
| May 3, 2016 | |||||||
| Mar 1, 2016 | |||||||
| Nov 5, 2015 | |||||||
| Aug 5, 2015 |